| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fortrea Holdings Inc. | General Counsel | Restricted Stock Unit | 24.4K | $607K | $24.85 | Jun 3, 2024 | Direct |
| Fortrea Holdings Inc. | General Counsel | Common Stock | 7.48K | $189K | $25.30 | Jun 12, 2024 | Direct |
| G1 Therapeutics, Inc. | General Counsel | Common Stock | 41.1K | $121K | $2.94 | Jan 5, 2023 | Direct |
| Fortrea Holdings Inc. | General Counsel | Common Stock | 25 | $633 | $25.30 | Jun 12, 2024 | By Son |
| G1 Therapeutics, Inc. | General Counsel | Stock Options (Right to buy) | 35.7K | Jan 3, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FTRE | Fortrea Holdings Inc. | Jun 12, 2024 | 1 | $50.6K | 4 | Jun 12, 2024 | General Counsel |
| FTRE | Fortrea Holdings Inc. | Jun 3, 2024 | 3 | -$55.4K | 4 | Jun 3, 2024 | General Counsel |
| FTRE | Fortrea Holdings Inc. | Mar 13, 2024 | 1 | $0 | 4 | Mar 15, 2024 | General Counsel |
| FTRE | Fortrea Holdings Inc. | Jun 30, 2023 | 1 | $0 | 4/A | Jul 19, 2023 | General Counsel |
| FTRE | Fortrea Holdings Inc. | Jun 20, 2023 | 1 | $0 | 4 | Jun 21, 2023 | General Counsel |
| FTRE | Fortrea Holdings Inc. | Jun 9, 2023 | 0 | $0 | 3 | Jun 9, 2023 | General Counsel |
| GTHX | G1 Therapeutics, Inc. | Jan 3, 2023 | 4 | -$13.1K | 4 | Jan 5, 2023 | General Counsel |
| GTHX | G1 Therapeutics, Inc. | Jan 3, 2022 | 3 | -$15.3K | 4 | Jan 5, 2022 | General Counsel |